| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H19Cl2NO5 |
| Molecular Weight | 304.1678 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H](CN(CCCl)CCCl)[C@H](O)[C@H](O)[C@@H](O)C=O
InChI
InChIKey=LXKPSLUQJMAWQY-XFWSIPNHSA-N
InChI=1S/C10H19Cl2NO5/c11-1-3-13(4-2-12)5-7(15)9(17)10(18)8(16)6-14/h6-10,15-18H,1-5H2/t7-,8+,9+,10-/m1/s1
| Molecular Formula | C10H19Cl2NO5 |
| Molecular Weight | 304.1678 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Galamustine (C6-galactose mustard or C6-GLM ) is a compound that has demonstrated anti-cancer activity. Its effect on cell growth and cell cycle kinetics was studied in leukemia. Because less bone marrow toxicity was reported for this compound compared to nitrogen mustard, the development of galamustine for clinical trials in humans was considered.
